Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Metelimumab> ?p ?o. }
Showing items 1 to 47 of
47
with 100 items per page.
- Metelimumab abstract "Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. Touted as a drug of the future, metelimumab was dropped from further development in favour of fresolimumab, which is currently being developed by Genzyme.".
- Metelimumab atcPrefix "none".
- Metelimumab casNumber "272780-74-2".
- Metelimumab wikiPageID "9132560".
- Metelimumab wikiPageRevisionID "546703969".
- Metelimumab atcPrefix "none".
- Metelimumab casNumber "272780".
- Metelimumab chemspiderid "NA".
- Metelimumab hasPhotoCollection Metelimumab.
- Metelimumab legalStatus "Investigational".
- Metelimumab mabType "mab".
- Metelimumab source "u".
- Metelimumab target TGF_beta_1.
- Metelimumab type "mab".
- Metelimumab verifiedfields "changed".
- Metelimumab verifiedrevid "458283946".
- Metelimumab subject Category:Monoclonal_antibodies.
- Metelimumab type Abstraction100002137.
- Metelimumab type Antibody115027189.
- Metelimumab type Chemical114806838.
- Metelimumab type Compound114818238.
- Metelimumab type Macromolecule114944888.
- Metelimumab type Material114580897.
- Metelimumab type Matter100020827.
- Metelimumab type Molecule114682133.
- Metelimumab type MonoclonalAntibodies.
- Metelimumab type MonoclonalAntibody115029781.
- Metelimumab type OrganicCompound114727670.
- Metelimumab type Part113809207.
- Metelimumab type PhysicalEntity100001930.
- Metelimumab type Protein114728724.
- Metelimumab type Relation100031921.
- Metelimumab type Substance100019613.
- Metelimumab type Thing100002452.
- Metelimumab type Unit109465459.
- Metelimumab type Drug.
- Metelimumab type DrugProduct.
- Metelimumab type FunctionalSubstance.
- Metelimumab comment "Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. Touted as a drug of the future, metelimumab was dropped from further development in favour of fresolimumab, which is currently being developed by Genzyme.".
- Metelimumab label "Metelimumab".
- Metelimumab label "ميتيليموماب".
- Metelimumab sameAs m.027ywm_.
- Metelimumab sameAs Q6823403.
- Metelimumab sameAs Q6823403.
- Metelimumab sameAs Metelimumab.
- Metelimumab wasDerivedFrom Metelimumab?oldid=546703969.
- Metelimumab isPrimaryTopicOf Metelimumab.